121 related articles for article (PubMed ID: 38555858)
1. Computational identification of potential modulators of heme-regulated inhibitor (HRI) for pharmacological intervention against sickle cell disease.
Owoloye AJ; Olubode SO; Ogunleye A; Idowu ET; Oyebola KM
J Biomol Struct Dyn; 2024 Mar; ():1-13. PubMed ID: 38555858
[TBL] [Abstract][Full Text] [Related]
2. Computational identification of potential modulators of heme-regulated inhibitor (HRI) for pharmacological intervention against sickle cell disease.
Owoloye AJ; Olubode SO; Ogunleye A; Idowu ET; Oyebola KM
Res Sq; 2023 Dec; ():. PubMed ID: 38168168
[TBL] [Abstract][Full Text] [Related]
3. HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation.
Peslak SA; Khandros E; Huang P; Lan X; Geronimo CL; Grevet JD; Abdulmalik O; Zhang Z; Giardine BM; Keller CA; Shi J; Hardison RC; Blobel GA
Blood Adv; 2020 Sep; 4(18):4560-4572. PubMed ID: 32956454
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches.
Ala C; Joshi RP; Gupta P; Ramalingam S; Sankaranarayanan M
J Biomol Struct Dyn; 2024; 42(1):261-273. PubMed ID: 37061929
[TBL] [Abstract][Full Text] [Related]
5. A chemoinformatic-biophysics based approach to identify novel anti-virulent compounds against
Al-Harbi AI; Ullah A; Almanaa TN; Gul F; Khan S; Waheed Y; Ul Haq M; Muhammad R; Khurram M; Ullah A; Ahmad S
J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37551016
[TBL] [Abstract][Full Text] [Related]
6. Lead optimization of
Ojo OA; Adegboyega AE; Taiwo OA; Olowosoke CB; Johnson GI; Umedum NL; Onuh K; Adeduro MN; Nwobodo VO; Elekan AO; Alemika TE; Johnson TO
J Biomol Struct Dyn; 2023 Dec; ():1-15. PubMed ID: 38109128
[TBL] [Abstract][Full Text] [Related]
7. The heme-regulated inhibitor kinase requires dimerization for heme-sensing activity.
Ricketts MD; Emptage RP; Blobel GA; Marmorstein R
J Biol Chem; 2022 Oct; 298(10):102451. PubMed ID: 36063997
[TBL] [Abstract][Full Text] [Related]
8. Carboxymuconolactone decarboxylase is a prospective molecular target for multi-drug resistant Acinetobacter baumannii-computational modeling, molecular docking and dynamic simulation studies.
Rana S; Skariyachan S; Uttarkar A; Niranjan V
Comput Biol Med; 2023 May; 157():106793. PubMed ID: 36944292
[TBL] [Abstract][Full Text] [Related]
9. Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.
Owoloye AJ; Ligali FC; Enejoh OA; Musa AZ; Aina O; Idowu ET; Oyebola KM
PLoS One; 2022; 17(8):e0268269. PubMed ID: 36026508
[TBL] [Abstract][Full Text] [Related]
10. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
11. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
Agarwal S; Kashaw SK
J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
[TBL] [Abstract][Full Text] [Related]
12. Screening of phytochemicals from
Yasmeen N; Ahmad Chaudhary A; K Niraj RR; Lakhawat SS; Sharma PK; Kumar V
J Biomol Struct Dyn; 2023 Dec; ():1-43. PubMed ID: 38141177
[TBL] [Abstract][Full Text] [Related]
13. Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study.
Holanda VN; Lima EMA; Silva WVD; Maia RT; Medeiros RL; Ghosh A; Lima VLM; Figueiredo RCBQ
J Biomol Struct Dyn; 2022 Aug; 40(12):5462-5480. PubMed ID: 33459182
[TBL] [Abstract][Full Text] [Related]
14. Computational insights into pediatric adenovirus inhibitors:
Sarkar K; Nandi S; Das RK
J Biomol Struct Dyn; 2023 Aug; ():1-14. PubMed ID: 37642990
[TBL] [Abstract][Full Text] [Related]
15.
Alharthi NS; Alwethaynani MS; Alhazmi AY; Alawam AS; Alshehri FF; Alotaibi F; Rehman ZU; Alkhayl FFA; Al-Bazi MM; Khan FR
J Biomol Struct Dyn; 2024 Feb; ():1-21. PubMed ID: 38385444
[TBL] [Abstract][Full Text] [Related]
16. Metabolites profiling and cheminformatics bioprospection of selected medicinal plants against the main protease and RNA-dependent RNA polymerase of SARS-CoV-2.
Lanrewaju AA; Enitan-Folami AM; Nyaga MM; Sabiu S; Swalaha FM
J Biomol Struct Dyn; 2023 Jul; ():1-21. PubMed ID: 37464870
[TBL] [Abstract][Full Text] [Related]
17. Virtual Screening of
Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
[TBL] [Abstract][Full Text] [Related]
18. Screening of potential phytomolecules against MurG as drug target in nosocomial pathogen
Lokhande KB; Pawar SV; Madkaiker S; Shrivastava A; Venkateswara SK; Nawani N; Wani M; Ghosh P; Singh A
J Biomol Struct Dyn; 2024; 42(1):495-508. PubMed ID: 36974974
[TBL] [Abstract][Full Text] [Related]
19. Computational insights into the interaction of small molecule inhibitors with HRI kinase domain.
Palrecha S; Lakade D; Kulkarni A; Pal JK; Joshi M
J Biomol Struct Dyn; 2019 Apr; 37(7):1715-1723. PubMed ID: 29663856
[TBL] [Abstract][Full Text] [Related]
20. Computational exploration of FOXM1 inhibitors for glioblastoma: an integrated virtual screening and molecular dynamics simulation study.
Swati K; Varma SR; Parameswari RP; Panda SP; Agrawal M; Prakash A; Kumar D; Agarwal P
J Biomol Struct Dyn; 2024 Feb; ():1-19. PubMed ID: 38305824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
